Tal Ben-Yishay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tal Ben-Yishay has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Marica Rosaria Ippolito
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy
14 shared publications - Sara Martin
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy
14 shared publications - Simone Scorzoni
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy
14 shared publications - Stefano Santaguida
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy
14 shared publications - Uri Ben-David
Department of Human Genetics & Computational Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel
14 shared publications - Yonatan Eliezer
Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
14 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between the highly-aneuploid clones (SS51, SS111) and the pseudo-diploid clone (SS48).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between the highly-aneuploid clones (SS51, SS111) and the pseudo-diploid clone (SS48).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Details of cell lines, reagents and oligonucleotides used in the study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Details of cell lines, reagents and oligonucleotides used in the study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- Open Access
- 7 January 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (2)
The cGAS–STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts
Ataxia–telangiectasia (A-T) is a pleiotropic genome instability syndrome resulting from the loss of the homeostatic protein kinase ATM. The complex phenotype of A-T includes progressive cerebellar degeneration, immunodeficiency, gonadal atrophy, interstitial lung disease, cancer predisposition, endocrine abnormalities, chromosomal instability, radiosensitivity, and segmental premature aging. Cultured skin fibroblasts from A-T patients exhibit premature senescence, highlighting the association between genome instability, cellular senescence, and aging. We found that lung fibroblasts derived from ATM-deficient mice provide a versatile experimental system to explore the mechanisms driving the premature senescence of primary fibroblasts lacking ATM. Atm −/− fibroblasts failed to proliferate under ambient oxygen conditions (21%). Although they initially proliferated under physiological oxygen levels (3%), they rapidly entered senescence. In contrast, wild-type (WT) lung fibroblasts did not senesce under 3% oxygen and eventually underwent immortalization and neoplastic transformation. However, rapid senescence could be induced in WT cells either by Atm gene ablation or persistent chemical inhibition of ATM kinase activity, with senescence induced by ATM inhibition being reversible upon inhibitor removal. Moreover, the concomitant loss of ATM and p53 led to senescence evasion, vigorous growth, rampant genome instability, and subsequent immortalization and transformation. Our findings reveal that the rapid senescence of Atm −/− lung fibroblasts is driven by the collaborative action of the cGAS–STING, p38 MAPK, and p53 pathways in response to persistent DNA damage, ultimately leading to the induction of interferon-α1 and downstream interferon-stimulated genes. We propose that accelerated cellular senescence may exacerbate specific A-T symptoms, particularly contributing to the progressive, life-threatening interstitial lung disease often observed in A-T patients during adulthood.
- 7 January 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (2)
Open AccessThe cGAS–STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts
Ataxia–telangiectasia (A-T) is a pleiotropic genome instability syndrome resulting from the loss of the homeostatic protein kinase ATM. The complex phenotype of A-T includes progressive cerebellar degeneration, immunodeficiency, gonadal atrophy, interstitial lung disease, cancer predisposition, endocrine abnormalities, chromosomal instability, radiosensitivity, and segmental premature aging. Cultured skin fibroblasts from A-T patients exhibit premature senescence, highlighting the association between genome instability, cellular senescence, and aging. We found that lung fibroblasts derived from ATM-deficient mice provide a versatile experimental system to explore the mechanisms driving the premature senescence of primary fibroblasts lacking ATM. Atm −/− fibroblasts failed to proliferate under ambient oxygen conditions (21%). Although they initially proliferated under physiological oxygen levels (3%), they rapidly entered senescence. In contrast, wild-type (WT) lung fibroblasts did not senesce under 3% oxygen and eventually underwent immortalization and neoplastic transformation. However, rapid senescence could be induced in WT cells either by Atm gene ablation or persistent chemical inhibition of ATM kinase activity, with senescence induced by ATM inhibition being reversible upon inhibitor removal. Moreover, the concomitant loss of ATM and p53 led to senescence evasion, vigorous growth, rampant genome instability, and subsequent immortalization and transformation. Our findings reveal that the rapid senescence of Atm −/− lung fibroblasts is driven by the collaborative action of the cGAS–STING, p38 MAPK, and p53 pathways in response to persistent DNA damage, ultimately leading to the induction of interferon-α1 and downstream interferon-stimulated genes. We propose that accelerated cellular senescence may exacerbate specific A-T symptoms, particularly contributing to the progressive, life-threatening interstitial lung disease often observed in A-T patients during adulthood.
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine